Platform trial
Also called: Adaptive platform trial · Topic: Human Capital: Education, Health and Demographic Dividend · NCERT: Beyond NCERT
Meaning
A platform trial (also called an adaptive platform trial) is a clinical trial that tests several vaccines or treatments at the same time under one master protocol. A protocol is the trial's rulebook: who can join, how results are measured, and when a candidate counts as working. The candidates usually share one comparison (control) group, so fewer volunteers are needed. New candidates can be added and failing ones dropped while the trial keeps running. This saves time in an outbreak, when there is only a short window to test candidates while patients are still being infected.
Example
In 2026, eastern DR Congo had an Ebola outbreak caused by Bundibugyo virus, and no vaccine was licensed against it. WHO's Tumaini trial tested candidate vaccines against this virus side by side under one protocol. During the trial, more candidates were added to it. One was ChAdOx1, developed by the University of Oxford with the Serum Institute of India.
Don't confuse with
- Conventional randomised controlled trial: tests one product against a control group under a fixed design. It ends once that single question is answered. A platform trial keeps going and lets candidates enter and leave.
- Phase one trial: a small first test in humans that checks only safety, not whether the product protects. "Phase" tells you how far a product has got in testing. "Platform" describes how the trial is organised.